Topics
Oligodendroglioma | Treatment | Targeted therapy | Abemaciclib
Home > Publications > Topics > Oligodendroglioma > Treatment > Targeted therapy > Abemaciclib
Wills CA, Mohan S, Nabavizadeh A, Patel T, Prior T, Mansour M,
McCoy E, Shah S, Angeloni N, O'Neill M, Frangos S, Blessing C,
Coghlan L, Maloney E, Wileyto EP, Desai AS, Bagley SJ.
A
single-arm phase 2 study of abemaciclib in adult
patients with recurrent grade 3
oligodendroglioma.
Neurooncol
Adv. 2025 Jan 17;7(1):vdaf011. doi:
10.1093/noajnl/vdaf011. PMID:
39944054. Interventional study.
ˍ